Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

593
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
593
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

653
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
653
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

476
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
476
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

354
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
354
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

878
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
878

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Effectiveness: Impact of Cladribine on Patient-Reported Outcomes and Quality of Life in Latin American Populations With Multiple Sclerosis.

Cureus·2026
Same author

Practical issues concerning the use of optical coherence tomography in multiple sclerosis in Latin America: Discussion from 19 centres on behalf of the Foro Latam EM study group.

Multiple sclerosis (Houndmills, Basingstoke, England)·2025
Same author

Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.

Brain : a journal of neurology·2024
Same author

Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).

Multiple sclerosis and related disorders·2024
Same author

Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.

Clinical neuropharmacology·2024
Same author

Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.

Journal of the neurological sciences·2024

Related Experiment Video

Updated: Dec 18, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.3K

Cannabis and multiple sclerosis.

Yara Dadalti Fragoso1,2, Adriana Carra3, Miguel Angel Macias4

  • 1Post-Graduate Program on Health and Environment, Universidade Metropolitana De Santos , Santos, Brazil.

Expert Review of Neurotherapeutics
|June 10, 2020
PubMed
Summary

Nabiximols, a cannabis-derived medication, effectively treats multiple sclerosis (MS) spasticity and pain when first-line drugs fail. While safe and effective, access is limited by cost and regulations, and smoking marijuana lacks scientific evidence for MS symptom relief.

Keywords:
Multiple sclerosiscannabislegislationnabiximolspainspasticity

More Related Videos

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

677
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

280

Related Experiment Videos

Last Updated: Dec 18, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.3K
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

677
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
03:43

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents

Published on: August 22, 2025

280

Area of Science:

  • Neurology
  • Pharmacology
  • Medical Cannabis

Background:

  • Multiple sclerosis (MS) commonly causes spasticity and pain, often inadequately managed by traditional first-line medications like baclofen, dantrolene, diazepam, and gabapentin.
  • Medical use of cannabis for MS symptoms has emerged, with some countries legalizing its therapeutic application, bypassing conventional clinical trials.
  • Cannabis-derived drugs have undergone testing and received approval for medical use in certain regions.

Purpose of the Study:

  • To evaluate the efficacy and safety of nabiximols, a cannabis-derived medication, for managing spasticity, pain, and urinary symptoms in patients with multiple sclerosis.
  • To review existing evidence on nabiximols in the context of MS treatment, particularly for cases resistant to standard therapies.

Main Methods:

  • Systematic review and analysis of data from 33 studies involving over 7,500 patients with MS.
  • Focus on studies conducted in the United Kingdom and Italy, assessing outcomes related to spasticity, pain, and urinary dysfunction.
  • Comparison of nabiximols' effectiveness against first-line oral medications for MS symptom management.

Main Results:

  • Nabiximols demonstrates consistent evidence of efficacy in improving MS-related spasticity, pain, and urinary symptoms.
  • The drug is considered safe and effective for patients with MS experiencing spasticity refractory to first-line oral treatments.
  • Data from 33 studies, including a significant number from the UK and Italy, support these findings.

Conclusions:

  • Nabiximols represents a safe and effective therapeutic option for MS patients with refractory spasticity and pain.
  • Current limitations in access to nabiximols, including legislative, bureaucratic, and cost barriers, hinder wider clinical adoption.
  • There is a lack of scientific evidence supporting the benefit of smoking marijuana for patients with MS.